Neoleukin Therapeutics

About:

Neoleukin Therapeutics is a pharmaceutical company that develops medicines to treat serious immunological disorders.

Twitter/X: neoleukin

Top Investors: Sahsen Ventures

Description:

Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. They are creating next generation immunotherapies using breakthrough de novo protein design technology. They use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.

Total Funding Amount:

$158M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2003-12-01

Contact Email:

contact(AT)neoleukin.com

Founders:

Jonathan Drachman

Number of Employees:

11-50

Last Funding Date:

2020-07-02

IPO Status:

Private

Industries: